copertina di Hybrid ablation therapy for atrial fibrillation - A focus on the convergent and team ...

Hybrid ablation therapy for atrial fibrillation - A focus on the convergent and team approaches

di Momin - Kaba • 2025 • dettagli prodotto

NOVITÀ • spedizione gratuita
normalmente disponibile
per la spedizione in 4-6 giorni lavorativi

da €45,00 a € 42,75

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

indice del testo pagine d'esempio

Aggiungi al carrello
Aggiungi alla lista dei desideri

DESCRIZIONE

Atrial fibrillation (AF) is a globally prevalent and increasingly common cardiac arrhythmia that often results in debilitating symptoms and a reduced quality of life.
While many patients respond to conventional medical therapies and catheter ablation, a subset of individuals suffers from highly resistant forms of AF that prove challenging to manage using standard approaches. In such cases, hybrid ablation therapies offer a promising alternative.
Among these, convergent hybrid ablation stands out as the least invasive technique. It combines the benefits of both surgical and catheter-based approaches, enabling more effective treatment of persistent AF. This procedure is typically performed without the need for intensive care unit (ICU) recovery, and most patients are discharged the following day - some even as same-day discharges.
Clinical outcomes have shown that, for carefully selected patients, convergent hybrid ablation offers superior success rates compared to standard catheter ablation, with relatively low complication rates.
This unique book provides a comprehensive insight into the evolving field of minimally invasive hybrid ablation for AF, serving as a valuable resource for treating resistant forms of this complex arrhythmia.